C3PO in the News
July 30, 2020
- Researchers at the University of Michigan’s Michigan Medicine and three other medical centers were awarded a total of $7 million from the National Heart, Lung, and Blood Institute (NHBLI) to study convalescent plasma in reducing symptoms of COVID-19 in patients with mild cases, Michigan Medicine announced Thursday.
- Michigan Medicine and three other medical centers receive $7 million COVID-19 outpatient convalescent plasma therapy trial
- Trump urges people who who have recovered from COVID-19 to donate blood plasma